Possibilities of Partial D3-Receptor Agonists Usage in Addictive Pathology

Effective Pharmacotherapy
doi 10.33978/2307-3586-2020-16-4-30-34
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medforum

Related search

Nicotine Receptor Partial Agonists for Smoking Cessation

2007English

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2016English

Role of Dopamine D3 Receptors in the Addictive Properties of Ethanol

Drugs of Today
MedicinePharmacology
2004English

Biphasic Effects of D3-Receptor Agonists, 7-Oh-Dpat anD PD128907, on the D1-Receptor Agonist-Induced Hyperactivity in Mice.

The Japanese Journal of Pharmacology
1997English

Assays for Enhanced Activity of Low Efficacy Partial Agonists at the D2dopamine Receptor

British Journal of Pharmacology
Pharmacology
2006English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Binding Modes of Full and Partial Agonists in the Orthosteric Binding Site of the Glycine Receptor

Biophysical Journal
Biophysics
2017English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Dopamine D3 Receptor mRNA and Renal Response to D3 Receptor Activation in Spontaneously Hypertensive Rats

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy